These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21146792)

  • 1. A review of hyaluronan and its ophthalmic applications.
    Rah MJ
    Optometry; 2011 Jan; 82(1):38-43. PubMed ID: 21146792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended release of hyaluronic acid from hydrogel contact lenses for dry eye syndrome.
    Maulvi FA; Soni TG; Shah DO
    J Biomater Sci Polym Ed; 2015; 26(15):1035-50. PubMed ID: 26176811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic applications of hyaluronan.
    Gaffney J; Matou-Nasri S; Grau-Olivares M; Slevin M
    Mol Biosyst; 2010 Mar; 6(3):437-43. PubMed ID: 20174672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of various hyaluronic acids produced by microbial fermentation for potential topical ophthalmic applications.
    Guillaumie F; Furrer P; Felt-Baeyens O; Fuhlendorff BL; Nymand S; Westh P; Gurny R; Schwach-Abdellaoui K
    J Biomed Mater Res A; 2010 Mar; 92(4):1421-30. PubMed ID: 19358259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes.
    Willen CM; McGwin G; Liu B; Owsley C; Rosenstiel C
    Eye Contact Lens; 2008 Jan; 34(1):43-5. PubMed ID: 18180683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current methods for treating the dry eye syndrome].
    Matevosova EA; Lutsevich EE; Safonova TN
    Vestn Oftalmol; 2009; 125(3):55-8. PubMed ID: 19566052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative investigation of treatments for evaporative dry eye].
    Khaireddin R; Schmidt KG
    Klin Monbl Augenheilkd; 2010 Feb; 227(2):128-34. PubMed ID: 19757354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin.
    Brown MB; Jones SA
    J Eur Acad Dermatol Venereol; 2005 May; 19(3):308-18. PubMed ID: 15857456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trehalose versus hyaluronan or cellulose in eyedrops for the treatment of dry eye.
    Matsuo T
    Jpn J Ophthalmol; 2004; 48(4):321-7. PubMed ID: 15295655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and optimization of a novel implantation technology in contact lenses for the treatment of dry eye syndrome: In vitro and in vivo evaluation.
    Maulvi FA; Shaikh AA; Lakdawala DH; Desai AR; Pandya MM; Singhania SS; Vaidya RJ; Ranch KM; Vyas BA; Shah DO
    Acta Biomater; 2017 Apr; 53():211-221. PubMed ID: 28131945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative studies of hyaluronan in marketed ophthalmic products.
    Liu XM; Harmon PS; Maziarz EP; Rah MJ; Merchea MM
    Optom Vis Sci; 2014 Jan; 91(1):32-8. PubMed ID: 24366432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of Hyaluronic Acid in Ophthalmology and Contact Lenses.
    Chang WH; Liu PY; Lin MH; Lu CJ; Chou HY; Nian CY; Jiang YT; Hsu YH
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33923222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The new role for eye care practitioners in management of dry eye-with and without contact lenses.
    Chalmers RL; Guillon M
    Cont Lens Anterior Eye; 2010 Apr; 33(2):47-8. PubMed ID: 20227635
    [No Abstract]   [Full Text] [Related]  

  • 14. Emerging treatments for dry eye: some like it hot, while others may prefer a good stimulation.
    Gicquel JJ; Bremond-Gignac D
    Br J Ophthalmol; 2013 May; 97(5):539-40. PubMed ID: 23077224
    [No Abstract]   [Full Text] [Related]  

  • 15. Ask the doctor. Recently my eyes have been more sensitive and irritated, and it's uncomfortable to wear my contact lenses. My eye doctor says I have dry eyes and advises artificial tears. Is there anything else I should do?
    Robb-Nicholson C
    Harv Womens Health Watch; 2012 Nov; 20(3):2. PubMed ID: 23326905
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cytotoxicity evaluation of three tear substitutes used in the treatment of dry eye syndromes].
    Debbasch C; Pisella PJ; Rat P; Warnet JM; Baudouin C
    J Fr Ophtalmol; 2000 Nov; 23(9):863-9. PubMed ID: 11084443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cyclosporine 0.05% ophthalmic emulsion for contact lens-intolerant patients.
    Hom MM
    Eye Contact Lens; 2006 Mar; 32(2):109-11. PubMed ID: 16538135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan as a promising excipient for ocular drug delivery.
    Guter M; Breunig M
    Eur J Pharm Biopharm; 2017 Apr; 113():34-49. PubMed ID: 27914235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of efficacy in the treatment of dry eye disease with 0.18% sodium hyaluronate ophthalmic solution (vismed, rejena).
    Tawfik HA
    Am J Ophthalmol; 2010 Nov; 150(5):757; author reply 757. PubMed ID: 21036218
    [No Abstract]   [Full Text] [Related]  

  • 20. [New therapeutic options for dry eye].
    Messmer EM
    Ophthalmologe; 2014 May; 111(5):410. PubMed ID: 24959646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.